CSMC IIT: Pilot Study of Phosphodiesterase-V Inhibition to Increase Intratumoral Concentration of Carboplatin in Patients With Recurrent High Grade Gliomas and Brain Metastases

Trial Profile

CSMC IIT: Pilot Study of Phosphodiesterase-V Inhibition to Increase Intratumoral Concentration of Carboplatin in Patients With Recurrent High Grade Gliomas and Brain Metastases

Discontinued
Phase of Trial: Phase 0

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Vardenafil (Primary) ; Carboplatin
  • Indications Brain metastases; Glioma
  • Focus Pharmacokinetics
  • Acronyms CSMC IIT; LevitraCarbo
  • Most Recent Events

    • 08 Sep 2017 Status changed from recruiting to discontinued.
    • 05 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top